Oral Abuse Potential Study of Nalbuphine
Clinical trial NCT04018664 · COMPLETED
Trial details
- NCT number
- NCT04018664
- Sponsor
- Trevi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2018-12-03
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.